NON-SEGMENTAL VITILIGO
Clinical trials for NON-SEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NON-SEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NON-SEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to bring back color to vitiligo skin
Disease control Not yet recruitingThis phase 2a trial tests whether a daily pill called ACT-777991 can help return color to the face of adults with non-segmental vitiligo. About 30 participants will take either the drug or a placebo for 24 weeks. Researchers will measure changes in skin color using a standard sco…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Idorsia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill could help restore skin color in vitiligo patients
Disease control Not yet recruitingThis study tests an experimental drug called D-2570 in 160 adults with non-segmental vitiligo, a condition that causes white patches on the skin. Participants take either D-2570 or a placebo pill once daily for 24 weeks, with an optional 24-week extension. The goal is to see if t…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC